Manager of the DAMP Lab to take the stage at SynBioBeta, joining over 150 other industry leaders convening in San Francisco to discuss the latest advances in the synthetic biology industry.
SAN FRANCISCO, CA, September 26, 2018—DAMP Lab Manager Marilene Pavan has been selected to speak at SynBioBeta 2018, the annual conference bringing together entrepreneurs, investors, policymakers and practitioners to drive the synthetic biology industry forward and find better, more sustainable ways to feed, fuel and heal the world. Other speakers at the industry’s premier event include genetics pioneer George Church, founder and managing partner of the Longevity Fund Laura Deming, and Creative Director of Ginkgo Bioworks, Christina Agapakis.
“Growth in synthetic biology’s technology, investment, talent, and innovation has continued to skyrocket over the past year, and we are so excited to see this year’s conference bring together all the most important players in the industry,” said SynBioBeta founder and CEO John Cumbers. “Synthetic biology is ready to turn traditional industry on its head and revolutionize the way we do business – in the same way that every company today is in some way an internet company, every company will one day be a biology company. SynBioBeta 2018 is the place to get ahead of that.”
Key themes at the SynBioBeta conference this year include the intersection of bio and tech; industrial revolution 2.0; biopharma and health; energy and environment; food and agriculture; the bioeconomy culture. Talks and panels will discuss the future of data storage through DNA, how synthetic biology is going to save us from nitrogen pollution, investment opportunities throughout the industry and why all companies need to be thinking about a Bio-Strategy in order to be able to compete.
“I am honored to speak at SynBioBeta and share our projects and views with other leaders in the industry,” said Marilene. “I will be participating in two panels: Global Biofoundries on Monday and Emerging Women Leaders in Synthetic Biology on Tuesday. I really hope to listen to other stories, connect with bright people, and share our vision about science automation and reproducibility. Coming from a modest part of Brazil I would never imagine that I would be speaking in an important event like this and I just can say a big thank you to John Cumbers and Prof. Douglas Densmore. Synthetic biology is a truly powerful way to change lives and I am proud to be part of this.”
Marilene’s research focuses on the automation of synthetic biology, with the aim of increase the throughput, quality, and reproducibility of the results. She is also organizing a workshop to happen on October 18th, at Boston University, named IWBMA (International Workshop in Bio-Manufacturing Automation). For more information about the IWBMA visit: damplab.org/events or contact email@example.com.
About DAMP Lab
In a moment where a number of cloud-based, automated synthetic biology laboratories are emerging, the DAMP Lab is a unique academic-located environment where in house software tools being developed to rapidly generate a large number of designs that implement desired functionality can be tested and integrated to the pipeline. Our goal is to have a complete synthetic biology technological stack, containing layers as “bioCAD tools”, “LIMS”, “Hardware”, and “Experimental Biology”, using formal representation of protocols. This will allow for more standardized and reproducible research results that can be transferred faster from academia to society. To know more about the DAMP Lab and how to partnership with us, please visit damplab.org or contact firstname.lastname@example.org.
SynBioBeta is the leading community of entrepreneurs, investors, policy makers and enthusiasts devoted to the responsible growth of the synthetic biology field. They host international synthetic biology conferences and events that bring the entire community together several times each year, giving anyone the opportunity to meet with the bright minds building and shaping the bio economy.
SynBioBeta also offers a highly specialized weekly industry e-digest, newswire and educational courses in addition to providing companies in the industry with opportunities for advertising, partnership, exhibition and sponsorships for promotion. For more information, visit www.synbiobeta.com.0